Sware Secures $6M to Help Life Sciences Eliminate Validation Debt
What You Should Know – Sware has secured $6 million in Series B funding to enhance its software validation solution for life sciences companies. – The new funding will support research and development, AI-driven capabilities, and expansion of Sware’s sales team to address validation debt. Insights into Sware’s Growth and Innovation Sware, a leading provider … Read More